Companies: 10,795·Total market cap: $144.5T
Valneva SE

Valneva SE

VALNNASDAQHealthcare● Active
$5.43
$-0.05(-0.91%)
Market Cap$483577789
P/E Ratio—
52W High$12.25
52W Low$5.06
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Valneva SE (VALN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001836564 · VALN · NASDAQ · as of Jun 8, 2026

Filing snapshot

258
Total Filings
6-K
Latest Form
2026-06-05
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001836564 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-17
Fiscal Year End
Mar 17, 2026
Accession No.
0001628280-26-018808
Primary Document
valn-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001836564 · Accession 0001628280-26-018808

Latest Key Filings

6-KQuarterly Report
6-K
2026-06-05
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-05
View
F-3F-3
REGISTRATION STATEMENT FOR SPECIFIED TRANSACTIONS BY CERTAIN FOREIGN PRIVATE ISS
2026-06-04
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-13
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-12
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-05
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-30
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-26
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-23
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-18
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-03-17
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-03-10
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-09
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-02
View
Showing 1–15 of 258 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001836564  |  Exchange: NASDAQ · Healthcare

Valneva SE (NASDAQ: VALN) has submitted 258 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001836564, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Valneva SE's most comprehensive regulatory disclosure. The most recent Valneva SE 10-K was filed on 2026-03-17 for fiscal year ending 2026. Historical VALN 10-K annual reports are available from 2021 through 2026.

Investors researching Valneva SE SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
DAWN SEC Filings →IOVA SEC Filings →AVBP SEC Filings →MBX SEC Filings →MGTX SEC Filings →REPL SEC Filings →GERN SEC Filings →ATXS SEC Filings →
→ VALN Financials→ VALN Earnings→ VALN Insider Trades

Frequently Asked Questions

VALN SEC Filings · 8 questions

Valneva SE (VALN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 258 filings and access original documents at no cost. Valneva SE's CIK is 0001836564.

VALN SEC filingsValneva SE SEC documentsfind VALN 10-K